Thursday, 23 August 2012

Liposomal Nanoparticles-Therapeutic Efficacy-Systemic Treatment-Treatment Response

The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients

ConclusionComorbidity influences systemic treatment uptake and adversely affects survival, with impact dependent upon comorbidity and cancer type. Clinical trials should be undertaken in older patients to better understand the risks and benefits of cancer treatments. (Source: Annals of Oncology) read more..

Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing?

ConclusionsProgress has been made in decreasing disparities in survival between nHw and minorities in breast cancer, prostate cancer, and NHL. Little progress has been made in reducing disparities for the other studied cancers. (Source: Annals of Oncology) read more..

Assessment of therapeutic efficacy of liposomal nanoparticles mediated gene delivery by molecular imaging for cancer therapy.

In conclusion, the combination of noninvasive imaging techniques and liposomal nanoparticle can provide a practical and clinically useful way for gene delivery and monitoring the level of gene expression over time and treatment response in patients undergoing gene therapy. PMID: 22888744 [PubMed - in process] (Source: Herpes) read more..

No comments:

Post a Comment